Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I emailed MK to let him know.
That’s ancient news article from when ticker was ADMD and CEO was James Katzaroff.
Given the surprise BDD announcement leads me to believe they’re closer than most think. Wouldn’t be surprised if submission news comes this month or by mid February at latest.
Great fiscal restraint shown by MK. Small amount overall and just enough to get this into the end zone and clinicals started. Awesome job!
I’ve added as well.
MK has been doing a stellar job. To run a company as well as he has and to bring it back from near extinction says volumes on his capabilities. To refuse to accept that one has to be a fool or a serial hater or both.
Agree unfortunately.
Same rinse and repeat post. Pathetic and embarrassing.
Hope everyone had a safe and happy New Year and that no one is suffering too terrible of a hangover! We took a couple days off to refresh. Back to work. See you guys about 30-45min before market open tomorrow. $NICH
— Nitches (@nitchescorp) January 1, 2024
Agree about profit taking and holding long term for FDA approval.
I expect there will be two run ups where we will see profit taking. IDE submission news and On IDE approval news and subsequent PRs.
I found this information regarding IDE medical device clinical testing.
https://www.greenlight.guru/blog/medical-device-clinical-trials
That’s what I think. The submission in itself is a material event requiring a PR but not positive.
I’d be surprised if Korenko does a blindside and announces IDE approval without announcing submission first.
I would like to see submission with a run up back to the $0.30-$0.50 range, given high probability of approval. The blindside will be when he announces approval post submission. There will be a lot of swing/flippers playing the submission run and trying to time exit before IDE approval/denial announcement.
I expect another spike post IDE approval then another settling in SP.
The unknown is how many PRs (and content) Vivos may put out post IDE approval news.
I do expect as PRs detail when clinical testing will start etc. will continue to drive SP higher with each phase. Still think uplisting will happen during clinicals.
Beginning is for those larger investors who’ve been waiting for IDE approval. Once approvals happens, if we can hold SP over a $1 for a period of months, I can see them uplisting.
The beginning really starts when IDE approval is granted. That’s when big players start coming in. The IDE approval, they will ride the rest of the way through clinicals and uplist. And given the current success with pet treatment, clinicals should be clear sailing imho.
Nice to end the last trading day of 2023 green. Real fun starts in January. GLTA !
Nice close in 7s to end the last trading day of 2023.
Let’s have an awesome 2024 with a great kickoff in January.
Excellent summary kayak!
Same. Trying to add more under $0.08 tomorrow and next week up until $0.10.
Yes indeed!!
Are you ready for the new year? We are and we’re preparing to start it off with a bang and some fireworks for our shareholders and the market. We want to be heard, will you be listening? $NICH
— Nitches (@nitchescorp) December 28, 2023
Low end of year activity with a few tax loss sells. Ready for January and 2024.
Nice. Appears anything purchased under .003 will be a great ROI going into January.
Sounds like the same guy I spoke to who said they got a Microsoft virus alert on my computer and I need to give them access to fix lol.
Link doesn’t show up.
That’s what Kamala told Big Willie Brown
Most likely because Korenko didn’t get the share price pop expected with the BDD announcement. Had the SP gone up and sustained about the original .08, I don’t think he would have submitted the amended offering.
I think Korenko would be ill advised to wait for results of IDE submission to make announcement of approval or denial. Vivos needs the increase in share price created by submission to have a much higher liftoff point upon approval. Benefits longs also as there’s an opportunity to skim profits or at least initial investment, or portion at least.
Having no submission news and just announcing IDE results, if a denial, obviously would be devastating. However given the FDA guided path Vivos has been on, approval outcome is still very high.
$RDGL !!! Next in couple months is IDE approval from FDA to start clinical trials on innovative cancer treatment. From $0.06-0.07 to $1+ on IDE approval. This is an amazing company and cancer treatment.
https://www.nasdaq.com/press-release/radiogeltm-precision-radionuclide-therapytm-receives-fda-breakthrough-device
$RDGL !!! Next in couple months is IDE approval from FDA to start clinical trials on innovative cancer treatment. From $0.06-0.07 to $1+ on IDE approval. This is an amazing company and cancer treatment.
https://www.nasdaq.com/press-release/radiogeltm-precision-radionuclide-therapytm-receives-fda-breakthrough-device
“Again, just stating the facts.” That no one would touch with a 39 1/2 ft pole.
LTG can respond but will add that this recent approval device designation pretty much guarantees IDE approval to move forward and start clinical trials. Mayo Clinic is already on board to start trials.
And given that radiogel product has been very successful with treatment of pet cancers, they should do great with clinical human trials.
Very good lol. We’ll get there.
We’ll get there in a few days. I’ll watch for the sell at $0.0901. So you at least exit with a penny profit for your trouble.
More swings and misses. Pathetic.
All us longs are getting ready for a hefty ROI.
Others who call themselves “objective longs. It what it is” will wither on the vine and disappear with a blackened soul full of hate the only thing they have remaining.
Wouldn’t be surprised if GS still had all his shares.
Nice! Here’s the link
Congratulations to $RDGL and Dr. Mike Korenko on their fantastic FDA news today. Perseverance will pay off here and I expect that RadioGel will soon be approved for human trials.
— George Sharp - Advocate for truth in the OTC (@GeorgeASharp) December 20, 2023
RDGL - Radiogel(TM) Precision Radionuclide Therapy(TM)... (https://t.co/1TY3c6cppZ)
Slowly accumulating a decent position in these lows.
Agree. The FDA is finally up against the wall and unable to move the goalposts any further. MK has been methodical and patient in moving the ball forward to get the IDE approval touchdown. I’m more
Confident than ever and to hold a major position through clinical trials.
Agree and good post LTG.
The post IDE approval will be a fun ride, but once the dust settles, the real fun begins, starting clinical trials. This is where the uplist and big investor money starts happening imo. I expect phase 1 to be a success given proven treatment history on pets already.
His cloak was removed a long time ago to reveal his true self and agenda. He was never a long. Never a free share holder. Purely out for vengeance and to destroy MK and the company no matter the cost. Truth and facts are irrelevant.